Injectable PLGA with EE and DSRP | The Contraceptive Pipeline Database

Product Overview

Development Status: Inactive

Target: Female

Mode: Hormonal

Delivery Type: Injectable

Duration Type: Long-acting

Description: A drug-delivery system of Poly(D,L-lactic-co-glycolic acid) (PLGA) microparticles and organogels containing drospirenone (DRSP) microcrystals combined with ethinyl estradiol (EE) PLGA microparticles and EE poly(butylcyanoacrylate) (PBCA) microcapsules.

Updated date: May 30, 2018

Vertical Tabs

Product Details

Active Pharmaceutical Ingredient (API): ethinyl estradiol, drospirenone

Potential Multi-Purpose Technology (MPT): No

Partner: Bayer HealthCare

Status

Programmatic Considerations

Additional Information

Additional Information:
Nippe S. (2012) Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release. Eur J Pharm Sci. 47(4):790-800.

Download Product Report